Table: begin end state 1 21 cytoplasmic 22 40 transmembrane 41 55 non-cytoplasmic 56 77 transmembrane 78 106 cytoplasmic 107 130 transmembrane 131 135 non-cytoplasmic 136 159 transmembrane 160 161 cytoplasmic 162 182 transmembrane 183 186 non-cytoplasmic 187 208 transmembrane 209 214 cytoplasmic 215 234 transmembrane 235 275 non-cytoplasmic 276 297 transmembrane 298 329 cytoplasmic 330 349 transmembrane 350 364 non-cytoplasmic 365 392 transmembrane 393 412 cytoplasmic 413 430 transmembrane 431 461 non-cytoplasmic
Input: >YP_001328063.1 NCBI__GCF_000017145.1:YP_001328063.1 MANVASTTASAGSELTARALREAVFAGLITLGLFVLFVGLKSDQNIRNELILTQRWGLLA IFVAVAMVGRFLIVVYVQPRFAKRKAAKAAAPDVVKKDTFFTRQWPKIAVVMLLLYPPVI VSFVGVQGSLKWVDNFGIQILIYVMLAWGLNIVVGLAGLLDLGYVAFYAVGAYSYALLSS YFGLSFWVLLPVAGLLAALWGIVLGFPVLRLRGDYLAIVTLAFGEIIRLVLINWTEVTKG TFGVSGIAKATLFGIKFDASKDGFAALFDLPLSSAYYKIFLFYLILALALLTAFVTIRLR RMPIGRAWEALREDEIACRSLGINTVTTKLTAFATGAMFGGFAGSFFAVRQGFVSPESFV FLESAVILAIVVLGGMGSLTGIAIAAVVMIGGTEILRELTFLKMIFGPAFTPELYRMLIF GLAMVTVMVWKPRGFVGSREPTAFLRQRRAVSGSFTKEGHG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server